Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
NCT01900951
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Small Cell
Interventions
DRUG:
Temozolomide
Sponsor
Chinese PLA General Hospital